BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16700133)

  • 1. [Concomitant nodular goiter during IFN and ribavirin treatment of HCV: a case report].
    Lin F; Wang HF
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):163, 166. PubMed ID: 16700133
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon + ribavirin combination therapy. Open new approach to treatment of patients with hepatitis C virus.
    Iino S
    Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):216-7. PubMed ID: 10379483
    [No Abstract]   [Full Text] [Related]  

  • 3. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
    Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
    Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of HCV infection and immunomodulating therapy (interferon-alpha and ribavirin) on the condition of minor salivary glands and oral mucosa].
    Sulka A; Simon K; Jeleń M; Piszko P
    Przegl Epidemiol; 2005; 59(2):455-66. PubMed ID: 16190554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New strategies for treatment of chronic hepatitis C].
    Rizzetto M
    Forum (Genova); 1999; 9(2 Suppl):1-11. PubMed ID: 11300125
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon plus ribavirin: a cautionary note.
    Macedo G; Ribeiro T
    Am J Gastroenterol; 1999 Oct; 94(10):3087-8. PubMed ID: 10520894
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination treatment for hepatitis C can be hazardous in patients co-infected with HIV.
    Schvarcz R; Moberg L; Sönnerborg A
    Antivir Ther; 1998; 3(4):233-4. PubMed ID: 10682144
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis C. Saving the liver].
    Paul A
    MMW Fortschr Med; 1999 Nov; 141(46):16. PubMed ID: 10795138
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic progresses of hepatitis C].
    Ma QY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):501-2. PubMed ID: 12939190
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hepatitis C in children].
    Ciocca M; Cuarterolo M; Ramonet M
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S34-5. PubMed ID: 20214295
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon-induced vitiligo in hepatitis C patients: a case series.
    Hamadah I; Binamer Y; Sanai FM; Abdo AA; Alajlan A
    Int J Dermatol; 2010 Jul; 49(7):829-33. PubMed ID: 20618507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic hepatitis C: present and future].
    Hezode C; Dhumeaux D
    Gastroenterol Clin Biol; 2000 May; 24(5):533-5. PubMed ID: 10891741
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?].
    Larrey D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B283-90. PubMed ID: 12180302
    [No Abstract]   [Full Text] [Related]  

  • 15. Ribavirin in chronic hepatitis C: past and future.
    Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of chronic hepatitis C in special groups].
    Bourlière M; Halfon P; Portal I
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B238-47. PubMed ID: 12180296
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recommendations from a Swedish meeting of experts. Hepatitis C is to be treated with the combination of interferon and ribavirin].
    Wejstål R; Fischler B; Glaumann H; Norkrans G; Reichard O; Sönnerborg A; Uhnoo I; Weiland O
    Lakartidningen; 1999 Nov; 96(44):4795-8, 4800. PubMed ID: 10584541
    [No Abstract]   [Full Text] [Related]  

  • 18. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
    Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
    Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term treatment with interferon-alpha can induce sarcoidosis. The connection can be stronger than earlier believed].
    Grunewald J; Andersson O; Berlin M; Bradley M; Zetterberg G; Weiland O; Eklund A
    Lakartidningen; 2006 Jun 28-Jul 11; 103(26-27):2045-8. PubMed ID: 16881277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.